© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Impairment of endothelium-independent vasodilation in patients with hypercalcemia
Departments of Cardiology, Vascular Medicine and Surgery, University of Vienna, Vienna, Austria
* Corresponding author. Tel.: +43-1-40400/4614; Fax: +43-1-408-1148.
Objective: Patients with primary hyperparathyroidism (PHPT) and/or hypercalcemia are at increased risk for myocardial ischemia. Whether PHPT is associated with altered endothelium-dependent dilation, vascular smooth muscle cell function, or both is unknown. This study was performed to test the hypothesis that endothelium-dependent, flow-mediated dilation (FMD) and/or endothelium-independent, nitroglycerin-induced dilation (NMD) is impaired in the preclinical phase of vascular disease in patients with PHPT. Methods: Twenty-six PHPT patients (mean±SD; age 55±15y, serum calcium 3.00±0.37 mmol/l, serum phosphate 0.79±0.21 mmol/l, iPTH 249±262 pg/ml) with no evidence of coronary artery disease (CAD) as well as 26 normocalcemic control subjects (CTL; age 51±12y) were studied. FMD following reactive hyperemia and NMD after 0.8 mg nitroglycerin (NTG) were assessed in the brachial artery by using high resolution ultrasound (7MHz). Results: NMD was impaired in PHPT patients compared to CTL (11.9±3.9% vs. 15.6±5.7%; p=0.012). FMD was similar in both study groups (11.6±4.6% vs. 12.6±4.9%; NS). The ratio of FMD to NMD was significantly different between PHPT patients and CTL (0.98±0.19 vs 0.81±0.25, p=0.009). On multiple stepwise regression analysis serum calcium was independently associated with the FMD/NMD ratio (r=0.34, p=0.017). Conclusions: Endothelium-independent vasodilation is impaired in PHPT patients without clinical evidence of coronary artery disease compared to normocalcemic CTL, while endothelium-dependent dilation was similar in both study groups. Thus, altered arterial reactivity in the course of PHPT may predominantly involve the arterial media and not the endothelium as observed previously in patients with various stages of atherosclerosis.
KEYWORDS Flow-mediated dilation; Nitroglycerin-induced vasodilation; Vascular disease; Hypercalcemia; Primary hyperparathyroidism; Ultrasound
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. J. Silverberg, E. M. Lewiecki, L. Mosekilde, M. Peacock, and M. R. Rubin Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 351 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Volzke, D. M. Robinson, T. Spielhagen, M. Nauck, A. Obst, R. Ewert, B. Wolff, H. Wallaschofski, S. B. Felix, and M. Dorr Are serum thyrotropin levels within the reference range associated with endothelial function? Eur. Heart J., January 2, 2009; 30(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rubin, M. S. Maurer, D. J. McMahon, J. P. Bilezikian, and S. J. Silverberg Arterial Stiffness in Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3326 - 3330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Chan, G. B. J. Mancini, L. Kuramoto, M. Schulzer, J. Frohlich, and A. Ignaszewski The prognostic importance of endothelial dysfunction and carotid atheromaburden in patients with coronary artery disease J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fallo, G. Camporese, E. Capitelli, G. M. Andreozzi, F. Mantero, and F. Lumachi Ultrasound Evaluation of Carotid Artery in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2096 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Shonni J. Silverberg; Cardiovascular Disease in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3513 - 3514. [Full Text]
|
|
|
|
|
|
J. C. Smith, M. D. Page, R. John, M. H. Wheeler, J. R. Cockcroft, M. F. Scanlon, and J. S. Davies Augmentation of Central Arterial Pressure in Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3515 - 3519. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Kosch, M. Hausberg, K. Vormbrock, K. Kisters, G. Gabriels, K. Heinz Rahn, and M. Barenbrock Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy Cardiovasc Res, September 1, 2000; 47(4): 813 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Neunteufl, U. Priglinger, S. Heher, M. Zehetgruber, G. Soregi, S. Lehr, K. Huber, G. Maurer, F. Weidinger, and K. Kostner Effects of vitamin E on chronic and acute endothelial dysfunction in smokers J. Am. Coll. Cardiol., February 1, 2000; 35(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|